The story of Viagra presents a interesting case for investors in the medicinal sector. While initially a tremendous success, generating vast sums, the intellectual property end and the subsequent flood of generic https://pharma466771.blogprodesign.com/63201756/the-little-copyright-and-the-pharmaceutical-industry-a-risky-bet